Create, Share, and Maintain NIH Biographical Sketches with SciENcv

The new NIH biosketch format will be required for grant applications submitted on or after May 25, 2015 – see our recent blog post for more information. To help with the transition, check out the Science Experts Network Curriculum Vitae (SciENcv), an online tool that helps researchers gather and compile personal information, such as expertise, employment, education and professional accomplishments, for re-use in grant submissions. Profiles can be created by entering data manually, copying an existing profile, or using an automated feed from an external source such as eRA Commons, National Science Foundation and ORCID (Open Researcher and Contributor ID).

Learn more about the recent ORCID Author Data Integration and check out this short video which focuses on the special features in SciENcv that help users create, share, and maintain NIH biosketch profiles:

Celebrating 350 Years of Philosophical Transactions of the Royal Society


This month marks a milestone in modern scientific publishing.  Back when science was called Natural Philosophy and the practice of medicine straddled the line between alchemy and butchery, the Royal Society started publishing (what is considered) the first peer-reviewed scientific journal. Volume 1 of Philosophical Transactions: Giving Some Accompt of the Present Undertakings, Studies, and Labours of the Ingenious in Many Considerable Parts of the World (as it was fully titled) was published 350 years ago this month.

The journal, which started as the Royal Society’s secretary Henry Oldenburg’s pet-project, was intended to communicate the most current information to society members and other scientifically minded readers. Since it’s first appearance in 1665, Philosophical Transactions has continued publication through plagues, wars, competition, and scandal. Continue reading

Liquid Biopsy Breakthrough for Early Stage Cancer Detection

Professor Dennis Yuk Ming Lo, associate dean of medicine at Chinese University, has developed a new method called liquid biopsy, which he claims can detect many kinds of cancer at a very early stage. Lo’s method decodes millions of DNA fragments in a human’s blood with the use of a DNA-sequencing machine. The results are then compared to that of a normal human genome or a complete set of human DNA. Researchers can now spot rearranged DNA patterns – a significant sign of a tumor. The liquid biopsy technology, cited by MIT Technology Review, is the result of over 20 years of research.